Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

BPMC Blueprint Medicines Corporation

104,96

-1,68 (-1,58%)

17 Mai 2024 - Fermé

Retardé de 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Blueprint Medicines (NASDAQ:BPMC)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024

Plus de graphiques de la Bourse Blueprint Medicines

Blueprint Medicines (NASDAQ:BPMC)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024

Plus de graphiques de la Bourse Blueprint Medicines

Actualités Blueprint Medicines Corporation

Form 4 - Statement of changes in beneficial ownership of securities
Vendredi 17 Mai 2024 ( il y a 4 heures) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Vendredi 17 Mai 2024 ( il y a 4 heures) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mercredi 15 Mai 2024 ( il y a 2 jours) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mercredi 15 Mai 2024 ( il y a 2 jours) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Vendredi 10 Mai 2024 ( il y a 1 semaine) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Lundi 6 Mai 2024 ( il y a 2 semaines) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Lundi 6 Mai 2024 ( il y a 2 semaines) • Edgar (US Regulatory)

Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Lundi 6 Mai 2024 ( il y a 2 semaines) • PR Newswire (US)

Blueprint Medicines Reports Strong First Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance
Jeudi 2 Mai 2024 ( il y a 2 semaines) • PR Newswire (US)

Blueprint Medicines to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024
Jeudi 18 Avril 2024 ( il y a 4 semaines) • PR Newswire (US)

Blueprint Medicines to Host Webcast and Conference Call Highlighting Emerging Opportunities for Mast Cell-Targeted Therapeutics
Jeudi 11 Avril 2024 ( il y a 1 mois) • PR Newswire (US)

Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jeudi 4 Avril 2024 ( il y a 1 mois) • PR Newswire (US)

Plus d'articles sur Blueprint Medicines Corporation

Blackrock Energy And Res...

Lavide Holdings NV

Banca Cesare Ponti

BNP PARIBAS ISSUANCE

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales